168 related articles for article (PubMed ID: 38260829)
1. Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer.
Li J; Wang D; Zhang C
Front Oncol; 2023; 13():1232192. PubMed ID: 38260829
[TBL] [Abstract][Full Text] [Related]
2. Pathomic model based on histopathological features and machine learning to predict IDO1 status and its association with breast cancer prognosis.
Zhuo X; Deng H; Qiu M; Qiu X
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38780888
[TBL] [Abstract][Full Text] [Related]
3. Prediction of TNFRSF9 expression and molecular pathological features in thyroid cancer using machine learning to construct Pathomics models.
Liu Y; Zhang J; Li S; Chen W; Wu R; Hao Z; Xu J
Endocrine; 2024 May; ():. PubMed ID: 38753243
[TBL] [Abstract][Full Text] [Related]
4. Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images.
Zhang K; Sun K; Zhang C; Ren K; Li C; Shen L; Jing D
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6075-6083. PubMed ID: 36653539
[TBL] [Abstract][Full Text] [Related]
5. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
6. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
[TBL] [Abstract][Full Text] [Related]
8. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
9. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
10. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
[TBL] [Abstract][Full Text] [Related]
12. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
13. A pathomic approach for tumor-infiltrating lymphocytes classification on breast cancer digital pathology images.
Verdicchio M; Brancato V; Cavaliere C; Isgrò F; Salvatore M; Aiello M
Heliyon; 2023 Mar; 9(3):e14371. PubMed ID: 36950640
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon.
Sun G; Duan H; Xing Y; Zhang D
Cancer Manag Res; 2021; 13():5113-5125. PubMed ID: 34234555
[TBL] [Abstract][Full Text] [Related]
15. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
16. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
Cao R; Yang F; Ma SC; Liu L; Zhao Y; Li Y; Wu DH; Wang T; Lu WJ; Cai WJ; Zhu HB; Guo XJ; Lu YW; Kuang JJ; Huan WJ; Tang WM; Huang K; Huang J; Yao J; Dong ZY
Theranostics; 2020; 10(24):11080-11091. PubMed ID: 33042271
[TBL] [Abstract][Full Text] [Related]
17. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
19. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.
Guo Y; Wang Z; Tian Y; Li L; Dong J
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511932
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
Zheng Y; Wu R; Wang X; Yin C
Front Public Health; 2022; 10():860381. PubMed ID: 35462848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
